These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 3525600)
1. The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique. Gardner DF; Arakaki RF; Podet EJ; Nell LJ; Thomas JW; Field JB J Clin Endocrinol Metab; 1986 Sep; 63(3):689-94. PubMed ID: 3525600 [TBL] [Abstract][Full Text] [Related]
2. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies. Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590 [TBL] [Abstract][Full Text] [Related]
3. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727 [TBL] [Abstract][Full Text] [Related]
4. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin. de Meijer PH; Lutterman JA Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752 [TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study. Cernea S; Kidron M; Wohlgelernter J; Raz I Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292 [TBL] [Abstract][Full Text] [Related]
6. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients. Shahshahani MN; Kitabchi J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713 [TBL] [Abstract][Full Text] [Related]
7. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. Hsia E; Seggelke S; Gibbs J; Hawkins RM; Cohlmia E; Rasouli N; Wang C; Kam I; Draznin B J Clin Endocrinol Metab; 2012 Sep; 97(9):3132-7. PubMed ID: 22685233 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors. Hildebrandt P Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533 [TBL] [Abstract][Full Text] [Related]
11. Effect of twice daily subcutaneous administration of a long-acting somatostatin analog on 24-hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus. Dimitriadis G; Gerich J Horm Metab Res; 1985 Oct; 17(10):510-1. PubMed ID: 2866155 [TBL] [Abstract][Full Text] [Related]
12. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus. Burge MR; Waters DL; Holcombe JH; Schade DS J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507 [TBL] [Abstract][Full Text] [Related]
13. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
14. Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. Roy B; Chou MC; Field JB J Clin Endocrinol Metab; 1980 Mar; 50(3):475-9. PubMed ID: 6987253 [TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique. Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772 [TBL] [Abstract][Full Text] [Related]
17. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects. Bantle JP; Neal L; Frankamp LM Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455 [TBL] [Abstract][Full Text] [Related]
18. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095 [TBL] [Abstract][Full Text] [Related]
19. Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients. Dandona P; Ghanim H; Green K; Sia CL; Abuaysheh S; Kuhadiya N; Batra M; Dhindsa S; Chaudhuri A Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E810-8. PubMed ID: 23403945 [TBL] [Abstract][Full Text] [Related]
20. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. DeFronzo R; Deibert D; Hendler R; Felig P; Soman V J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]